KRT16 Gene: Keratin 16

Key player in epithelial integrity, wound healing, and genetic disorders including pachyonychia congenita.

Gene Information Card

Symbol KRT16
Full Name Keratin 16
Gene Type protein-coding
Chromosomal Location 17q21.2
NCBI Gene ID 3868 ncbi.nlm.nih.gov/gene/3868
Ensembl ID ENSG00000186832
UniProt ID P08779
OMIM ID 148067
HGNC ID 6423
Aliases CK16, K16, KRT16A, NEPPK

Description

KRT16 encodes keratin 16, a type I intermediate filament protein expressed in suprabasal keratinocytes of stratified epithelia. It forms heteropolymers with keratin 6 (KRT6A, KRT6B, KRT6C) and is essential for maintaining epithelial structural integrity. KRT16 is rapidly induced upon wounding and in hyperproliferative states such as psoriasis and cancer. Mutations in KRT16 cause pachyonychia congenita type 1 (PC-1) and focal palmoplantar keratoderma (FPPK).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Pachyonychia congenita 1 (PC-1) Missense mutations in the helix initiation or termination domains disrupt keratin filament assembly, leading to fragility of nail bed, palmoplantar epidermis, and oral mucosa. ClinVar, OMIM #167200
Focal palmoplantar keratoderma (FPPK) Mutations in the 1A or 2B rod domain impair heterodimerization with KRT6, causing localized hyperkeratosis and blistering on palms and soles. OMIM #148067, ClinVar
Steatocystoma multiplex Rare missense variants in KRT16 are associated with cyst formation in sebaceous ducts, likely due to altered keratinocyte adhesion. ClinVar, OMIM #184500

Expression Profile

Tissue Expression
Tissue nTPM level
Skin 78.5 High
Esophagus 45.2 Medium
Oral mucosa 62.1 High
Lung 3.4 Low
Breast 1.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
HaCaT (keratinocyte) 89.3 High expression; used as model for epidermal differentiation
A431 (epidermoid carcinoma) 72.1 Overexpressed due to hyperproliferative state
MCF7 (breast cancer) 2.5 Low; not a keratinocyte lineage
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.374A>G (p.Asn125Ser) Missense Common in PC-1 Disrupts helix initiation motif; dominant-negative effect
c.1406G>A (p.Arg469His) Missense Rare in FPPK Impairs filament elongation
c.1A>G (p.Met1Val) Start loss Very rare Loss of function; associated with mild PC phenotype
Mutation functional classification

Loss of Function (LOF)

Start-loss mutations (e.g., p.Met1Val) reduce protein production, leading to haploinsufficiency and mild epithelial fragility.

Gain of Function (GOF)

Not established for KRT16; most pathogenic mutations are dominant-negative.

Dominant Negative (DN)

Missense mutations in the rod domain (e.g., p.Asn125Ser) produce defective keratins that incorporate into filaments, disrupting network integrity.

Gene Ontology (GO)

• structural constituent of skin epidermis • intermediate filament organization
• keratin filament binding • response to wounding
• epidermis development

Pathways

Intermediate filament polymerization
Keratinization
Wound healing (KRT16 induction)

Protein Summary

Keratin 16 is a 473-amino-acid type I intermediate filament protein (48.5 kDa) with a central alpha-helical rod domain flanked by non-helical head and tail domains. It heteropolymerizes with type II keratins (KRT6) to form 10-nm filaments that provide mechanical resilience to suprabasal keratinocytes. KRT16 is constitutively expressed in palmoplantar epidermis, nail bed, and oral mucosa, and is induced in hyperproliferative conditions. Mutations in the conserved helix boundaries cause dominant-negative disruption of filament assembly, leading to pachyonychia congenita and focal palmoplantar keratoderma.

Related Products

Product name Cat.No. Species Gene ID
KRT16 Knockout HEK293 Cell Line EDJ-KQ5091 Human 3868 Details Get a Quote
KRT16 Knockout HeLa Cell Line EDJ-KQ28037 Human 3868 Details Get a Quote
KRT16 Knockout A-549 Cell Line EDJ-KQ62238 Human 3868 Details Get a Quote
KRT16 Knockout HCT 116 Cell Line EDJ-KQ70722 Human 3868 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: